Monthlyupdate - Central & peripheral nervous systems: Pharmacotherapeutic potential for compounds acting at NMDA receptors: Update 1995

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  1995-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/13543784.4.5.475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem

  2004cited by this paper
• Safety, Tolerability, and Pharmacokinetics of the N-Methyl-d-Aspartate Antagonist Dextrorphan in Patients With Acute Stroke

  1995cited by this paper
• Glutamate-mediated astrocyte–neuron signalling

  1994cited by this paper
• Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.

  1994cited by this paper
• The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.

  1994cited by this paper
• Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.

  1994cited by this paper
• Antiepileptics inhibit cortical N-methyl-D-aspartate-evoked [3H]norepinephrine efflux.

  1994cited by this paper
• Selective antagonism of the anticonvulsant effects of felbamate by glycine.

  1994cited by this paper
• Prophylactic Neuroprotection for Cerebral Ischemia

  1994cited by this paper
• Amelioration of negative symptoms in schizophrenia by glycine.

  1994cited by this paper
• Effects of nitric oxide synthase inhibitors on N-methyl-D-aspartate-induced phase delay of circadian rhythm of neuronal activity in the rat suprachiasmatic nucleus in vitro.

  1994cited by this paper
• 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.

  1994cited by this paper
• The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum.

  1994cited by this paper
• Synthesis, NMDA receptor antagonist activity, and anticonvulsant action of 1-aminocyclobutanecarboxylic acid derivatives.

  1994cited by this paper
• The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat

  1994cited by this paper
• Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.

  1994cited by this paper
• Antinociception induced by 3-((±)-2-car☐ypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), an N-methyl-d-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX

  1994cited by this paper
• The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition

  1994cited by this paper
• Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors

  1994cited by this paper
• Over-additive protective effect of dizocilpine and NBQX against neuronal damage.

  1994cited by this paper
• Characterization of the solubilized NMDA receptor complex from rat brain with [3H]L-689,560, a glycine site antagonist.

  1994cited by this paper
• Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

  1994cited by this paper
• Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.

  1994cited by this paper
• Effect of L‐glutamic acid on acid secretion and immunohistochemical localization of glutamatergic neurons in the rat stomach

  1994cited by this paper
• Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death.

  1994cited by this paper
• NMDA receptor (NMDAR1) expression in the rat hippocampus after forebrain ischemia.

  1994cited by this paper
• Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients.

  1994cited by this paper
• Death of cultured postnatal rat CNS neurons by in vitro hypoxia with special reference to N-methyl-D-aspartate-related toxicity.

  1994cited by this paper
• Glutamate and Parkinson's disease

  1994cited by this paper
• Release of adenosine by activation of NMDA receptors in the hippocampus.

  1994cited by this paper
• Neuroprotective Effect of the AMPA Receptor Antagonist LY-293558 in Focal Cerebral Ischemia in the Cat

  1994cited by this paper
• New Pharmacological Strategies for Cognitive Enhancement Using a Rat Model of Age‐Related Memory Impairment

  1994cited by this paper
• Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.

  1994cited by this paper
• Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists

  1994cited by this paper
• Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn.

  1994cited by this paper
• Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids.

  1994cited by this paper
• Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor.

  1994cited by this paper
• Dextromethorphan: Cellular Effects Reducing Neuronal Hyperactivity

  1994cited by this paper
• D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain.

  1994cited by this paper
• Glutamatergic Control of Dopamine Release During Stress in the Rat Prefrontal Cortex

  1994cited by this paper
• The NMDA Receptor antagonists, LY274614 and MK‐801, and the nitric oxide synthase inhibitor, NG‐nitro‐L‐arginine, attenuate analgesic tolerance to the mu‐opioid morphine but not to kappa opioids

  1994cited by this paper
• D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors.

  1994cited by this paper
• Long-lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats.

  1994cited by this paper
• Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acidA receptors

  1994cited by this paper
• Malonate produces striatal lesions by indirect NMDA receptor activation.

  1994cited by this paper
• Oxcarbazepine: Mechanisms of Action

  1994cited by this paper
• Molecular biology of glutamate receptors.

  1994cited by this paper
• Prevention of Periinfarct Direct Current Shifts with Glutamate Antagonist NBQX following Occlusion of the Middle Cerebral Artery in the Rat

  1994cited by this paper
• Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA

  1994cited by this paper
• Gangliosides in the protection against glutamate excitotoxicity.

  1994cited by this paper
• Protein Kinase C Activation Attenuates N‐Methyl‐d‐Aspartate‐Induced Increases in Intracellular Calcium in Cerebellar Granule Cells

  1994cited by this paper
• Repeated NMDA receptor activation induces distinct intracellular calcium changes in subpopulations of striatal neurons in vitro.

  1993cited by this paper
• Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.

  1993cited by this paper
• Dextromethorphan inhibits NMDA-induced convulsions.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper

• Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

  2025cites this paper
• Combination Therapy with Neuroprotectants and Thrombolytics in Acute Ischaemic Stroke

  1998cites this paper
• Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

  1997cites this paper
• The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors.

  1996cites this paper